Merger activity remained unchanged last week with four new deals announced and one deal closing. You can find all the active deals listed below in our Merger Arbitrage Tool (MAT) that automatically updates itself during market hours.
There were no new deals announced in the Deals in the Works section.
Deal Statistics:
Total Number of Deals Closed in 2019 | 121 |
Total Number of Deals Not Completed in 2019 | 8 |
Total Number of Pending Deals | |
Cash Deals | 50 |
Stock Deals | 16 |
Stock & Cash Deals | 13 |
Special Conditions | 5 |
Total Number of Pending Deals | 84 |
Aggregate Deal Consideration | $1.13 trillion |
New Deals:
Deal Updates:
Closed Deals:
Top deals with largest spreads:
Symbol | Announced Date | Acquiring Company | Closing Price | Last Price | Closing Date | Profit | Annualized Profit |
---|---|---|---|---|---|---|---|
STC | 03/19/2018 | Fidelity National Financial, Inc. (FNF) | $52.97 | $34.58 | 09/30/2019 | 53.19% | 554.74% |
PACB | 11/01/2018 | Illumina, Inc. (ILMN) | $8.00 | $5.61 | 12/31/2019 | 42.60% | 122.44% |
ABDC | 08/13/2019 | Crescent Capital BDC, Inc. (N/A) | $11.02 | $8.83 | 12/31/2019 | 24.80% | 71.28% |
GNW | 10/23/2016 | China Oceanwide Holdings Group Co., Ltd. (N/A) | $5.43 | $4.39 | 12/31/2019 | 23.69% | 68.09% |
MLNX | 03/11/2019 | NVIDIA Corporation (NVDA) | $125.00 | $106.48 | 12/31/2019 | 17.39% | 49.99% |
S | 04/29/2018 | T-Mobile US, Inc. (TMUS) | $7.84 | $6.74 | 01/31/2020 | 16.38% | 37.83% |
OHAI | 08/01/2019 | Portman Ridge Finance Corporation (PTMN) | $1.46 | $1.26 | 12/31/2019 | 15.87% | 45.62% |
ONCE | 02/25/2019 | Roche Holding AG (RHHBY) | $114.50 | $100.78 | 04/30/2020 | 13.61% | 20.04% |
AVP | 05/22/2019 | Natura Cosméticos S.A. (NATU3.SA) | $4.45 | $3.93 | 01/31/2020 | 13.24% | 30.59% |
List of all pending deals:
Disclaimer: I hold long positions in Mellanox Technologies (MLNX), Pacific Biosciences of California (PACB), Celgene (CELG), Bristol-Myers Squibb (BMY) and Finisar (FNSR). Please do your own due diligence before buying or selling any securities mentioned in this article. We do not warrant the completeness or accuracy of the content or data provided in this article.
Connect with me on LinkedIn: http://www.linkedin.com/in/asifsuria or follow me on Twitter@asifsuria